Drug Topics
NOVEMBER 19, 2024
Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.
Pharmacy Times
NOVEMBER 19, 2024
Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 19, 2024
When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost. Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.
Fierce Healthcare
NOVEMBER 19, 2024
The FDA will hold its first Digital Health Advisory Committee (DHAC) meeting to discuss how the agency should review medical devices that rely on generative AI, like chatbots. | The FDA seeks advice on regulatory challenges it has identified for generative AI used in medical devices, which include uncertainty about the foundation model, hallucinations and the ability to define intended use.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
NOVEMBER 19, 2024
An increase of shingles vaccination was reported among individuals with asthma.
Fierce Healthcare
NOVEMBER 19, 2024
More than half of health system and health plan executives say AI is an immediate priority, and 73% are increasing their investments in the technology, a new C-suite survey finds. | More than half of health system and health plan executives say AI is an immediate priority, and 73% are increasing their investments in the technology, a new C-suite survey finds.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
NOVEMBER 19, 2024
Mike Pykosz, the former CEO of Oak Street Health, will leave CVS Health as part of the company's latest leadership shake-up. | Mike Pykosz, the former CEO of Oak Street Health, will leave CVS Health as part of the company's latest leadership shake-up.
STAT
NOVEMBER 19, 2024
Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall industry efforts remain limited and patient access continues to suffer as a result. Notably, momentum has stalled in reaching licensing deals that are designed to make lower-cost generic drugs available in parts of the world where brand-name medicines are unaffordable, and few companies have pursued technology transfer agreements.
Fierce Healthcare
NOVEMBER 19, 2024
Cyberattacks against healthcare organizations are becoming increasingly sophisticated, with new threats constantly emerging. | This week on "Podnosis," we explore the rise of voice phishing, or vishing, where cybercriminals use AI to mimic voices and breach sensitive healthcare data.
Pharmacy Times
NOVEMBER 19, 2024
Christine Formea, PharmD, MHI, BCPS, FCCP, FASHP, discusses the need for standardized pharmacogenomics education in pharmacy, highlighting opportunities for collaboration, professional growth, and integration of key competencies across curricula to advance the profession.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
NOVEMBER 19, 2024
Below is a roundup of payer-centric news headlines you may have missed during the month of November 2024. | In this month's payer roundup, a man was charged with insider trading for purchasing Oak Street Health stock before CVS made public the acquisition, the DOJ is honing in on pharmacy benefit managers and OIG found Medicare improperly paid acute-care hospitals by $190 million.
Pharmacy Times
NOVEMBER 19, 2024
Clinical trial analysis results studying VAD-44 in patients with hereditary hemorrhagic telangiectasia (HTT) will be presented at the 2024 American Society of Hematology Annual Meeting & Exposition.
STAT
NOVEMBER 19, 2024
Merck said a new formulation of the best-selling drug, Keytruda, appears to deliver similar blood levels of the medicine when it is given as a shot as when it is given intravenously. For Merck, the new under-the-skin, or subcutaneous, formulation of Keytruda could represent a major way of holding on to a larger share of Keytruda’s $25 billion in annual sales than would otherwise occur when the medicine’s U.S. patent expires in 2028.
Pharmacy Times
NOVEMBER 19, 2024
GNSC-001 is a first-in-class gene therapy designed to offer long-term relief of musculoskeletal diseases such as osteoarthritis.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
NOVEMBER 19, 2024
AbbVie’s head of R&D cures has lofty ambitions to end diseases like HIV through a community of researchers that work as one.
Pharmacy Times
NOVEMBER 19, 2024
Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.
Drug Topics
NOVEMBER 19, 2024
Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.
PharmaVoice
NOVEMBER 19, 2024
The company is looking to score an FDA nod for its investigational therapy that targets a molecule linked to Guillain-Barré syndrome and other autoimmune diseases.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
NOVEMBER 19, 2024
Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.
pharmaphorum
NOVEMBER 19, 2024
GSK has reported promising phase 3 results with linerixibat in treating severe itching that plagues patients with primary biliary cholangitis
Drug Topics
NOVEMBER 19, 2024
Drug Topics talked with Kelly Malkamaki, pharmacist, former independent community pharmacy owner, and senior product pharmacy analyst at AssureCare, about how community pharmacies can continue to thrive with decreased medication reimbursement rates.
Fierce Pharma
NOVEMBER 19, 2024
As BeiGene works to grow the reach of its cancer offerings, the company inked a patent settlement with MSN over its star medicine Brukinsa.
Drug Topics
NOVEMBER 19, 2024
Adam J. James, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.
pharmaphorum
NOVEMBER 19, 2024
Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of volunteers into clinical trials, aiming to solve a major obstacle in clinical research.Patient recruitment remains a major challenge for trial sponsors and can lead to delays and increased costs, and traditional methods can be time-consuming and inefficient.
The Checkup by Singlecare
NOVEMBER 19, 2024
Doxycycline and amoxicillin are two commonly prescribed and used antibiotics in medicine. However, they belong to different drug classes and are often used for different types of bacterial infections. Doxycycline is a tetracycline antibiotic that works by stopping bacterial growth. It’s typically prescribed for skin conditions like rosacea and acne because it also reduces inflammation.
pharmaphorum
NOVEMBER 19, 2024
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial
The Checkup by Singlecare
NOVEMBER 19, 2024
Amoxicillin is a type of penicillin antibiotic used to treat various bacterial infections. It works by killing bacteria and stopping infection from spreading. Amoxicillin is approved by the Food and Drug Administration (FDA) to treat bacterial infections affecting the nose, ear, and throat, as well as lower respiratory tract infections, sinus infections, ulcers, and skin infections.
Pharmacy Times
NOVEMBER 19, 2024
Harpreet Bhatia, MD, MAS, FACC, discusses emerging new approaches to lipid lowering therapies.
The Checkup by Singlecare
NOVEMBER 19, 2024
When you or someone you care for come down with the common cold or the flu , the only thing you want is relief—and the faster, the better. The dizzying array of over-the-counter (OTC) painkillers and cold medications can get confusing, especially if there’s no single drug that will solve all your symptoms. Theraflu and ibuprofen are two common OTC medications for symptom relief.
Fierce Healthcare
NOVEMBER 19, 2024
FeelBetter, a startup that launched six years ago, is expanding its AI-based medication management platform into long-term care through a partnership with Americare. | FeelBetter, a startup that launched six years ago, is expanding its AI-based medication management platform into long-term care through a partnership with Americare.
Outsourcing Pharma
NOVEMBER 19, 2024
The financing round will fund the improvement of the companyâs technology platform for the discovery and development of innovative radionuclide drug conjugates.
STAT
NOVEMBER 19, 2024
Ambient AI medical scribes are about the easiest — and hottest — way into health care for AI-based startups. Just take a look at this graphic that lists 35 companies who are (or at one point were) trying to use ambient voice for translating the audio of doctors’ visits into written notes. The area is both well within the capabilities of AI tools and also — theoretically — doesn’t directly affect patient care.
Outsourcing Pharma
NOVEMBER 19, 2024
Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.
Expert insights. Personalized for you.
218 
Let's personalize your content